We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
-4.09%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.52B
AUM Growth
-$173M
Cap. Flow
-$49.2M
Cap. Flow %
-1.95%
Top 10 Hldgs %
37.25%
Holding
3,473
New
218
Increased
908
Reduced
1,467
Closed
292
Avg Time Held Equity + Options
3 years
Top 10 Avg Time Held Equity + Options
2.4 years
Top 20 Avg Time Held Equity + Options
2.4 years
Avg Time Held Equity only
3 years
Top 10 Avg Time Held Equity only
2.4 years
Top 20 Avg Time Held Equity only
2.4 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 51.1%
2 Technology 15.39%
3 Financials 8.2%
4 Healthcare 7.16%
5 Consumer Discretionary 5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
RLGT icon
3226
Radiant Logistics
RLGT
$428M
– –
-140
Closed -$1K –
RNAM
3227
DELISTED
Avidity Biosciences
RNAM
– –
-171
Closed -$4K –
RNAC icon
3228
Cartesian Therapeutics
RNAC
$202M
$0 ﹤0.01%
3
– –
2020 Q4
5 quarters
RNP icon
3229
Cohen & Steers REIT and Preferred and Income Fund
RNP
$883M
$0 ﹤0.01%
3
– –
2020 Q4
5 quarters
ROCK icon
3230
Gibraltar Industries
ROCK
$1.17B
– –
-2
Closed – –
RRR icon
3231
Red Rock Resorts
RRR
$3.03B
– –
-36
Closed -$2K –
RSI icon
3232
Rush Street Interactive
RSI
$2.19B
– –
-61
Closed -$1K –
RWR icon
3233
State Street SPDR Dow Jones REIT ETF
RWR
$1.79B
– –
-6
Closed -$1K –
RWX icon
3234
State Street SPDR Dow Jones International Real Estate ETF
RWX
$244M
– –
-31
Closed -$1K –
RXRX icon
3235
Recursion Pharmaceuticals
RXRX
$2.13B
– –
-151
Closed -$3K –
RXT icon
3236
Rackspace Technology
RXT
$782M
$0 ﹤0.01%
19
+7
+58% +$83
2021 Q1
4 quarters
RYAM icon
3237
Rayonier Advanced Materials
RYAM
$482M
$0 ﹤0.01%
+15
New +$91
2022 Q1
0 quarters
RYZ icon
3238
Ryerson Holding Corp
RYZ
$1.4B
$0 ﹤0.01%
+5
New +$136
2022 Q1
0 quarters
RYTM icon
3239
Rhythm Pharmaceuticals
RYTM
$6.16B
– –
-50
Closed – –
SAGE icon
3240
DELISTED
Sage Therapeutics
SAGE
– –
-176
Closed -$7K –
SAH icon
3241
Sonic Automotive
SAH
$2.06B
– –
-6
Closed – –
FLNA icon
3242
Filana Therapeutics
FLNA
$35.6M
$0 ﹤0.01%
10
-2
-17% -$85
2021 Q1
4 quarters
SDGR icon
3243
Schrodinger
SDGR
$1.87B
$0 ﹤0.01%
8
-20
-71% -$608
2020 Q4
5 quarters
SGMO icon
3244
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
– –
-118
Closed -$1K –
SHC icon
3245
Sotera Health
SHC
$5.11B
– –
-84
Closed -$2K –
SHM icon
3246
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.49B
– –
-22,194
Closed -$1.09M –
SIGA icon
3247
SIGA Technologies
SIGA
$225M
– –
-795
Closed -$6K –
SLDB icon
3248
Solid Biosciences
SLDB
$599M
$0 ﹤0.01%
+7
New +$124
2022 Q1
0 quarters
SLE icon
3249
Super League Enterprise
SLE
$9.23M
– –
0
– -$2K
2021 Q2
3 quarters
SLP icon
3250
DELISTED
Simulations Plus
SLP
$0 ﹤0.01%
7
– –
2021 Q1
4 quarters

Similar funds

Parallel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Parallel Advisors held 3,473 positions worth $2.52B, down 6.4% from $2.69B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parallel Advisors's Q1 2022 filing shows 218 new, 908 increased, 1,467 reduced and 292 closed positions. Its largest new stake was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M. The largest sale was Vanguard ESG US Stock ETF, an estimated $9.63M.

By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, down from 51% a quarter earlier, followed by Technology and Financials.

  • Parallel Advisors's largest Q1 2022 buy was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M.
  • Parallel Advisors added most to iShares Fallen Angels USD Bond ETF in Q1 2022, an estimated $9.31M increase.
  • Parallel Advisors's biggest Q1 2022 reduction was Vanguard ESG US Stock ETF, cutting an estimated $9.63M.
  • Parallel Advisors fully exited State Street SPDR Nuveen ICE Short Term Municipal Bond ETF in Q1 2022, selling an estimated $1.09M.
  • Parallel Advisors's ten largest holdings make up 37% of its $2.52B portfolio in Q1 2022.
  • Parallel Advisors opened 218 new positions and closed 292 in Q1 2022.
  • Parallel Advisors's portfolio value fell 6.4% quarter-over-quarter to $2.52B.

Based on Parallel Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.